Log in
Enquire now
Be Biopharma

Be Biopharma

Be Biopharma is developing a proprietary class of engineered B cells as medicines in applications beyond cytotoxicity.

OverviewStructured DataIssuesContributors

Contents

be.bio
Is a
Company
Company
Organization
Organization

Company attributes

Industry
Biotechnology
Biotechnology
Health technology
Health technology
Technology
Technology
Location
Cambridge, Massachusetts
Cambridge, Massachusetts
0
B2X
B2B
B2B
CEO
‌
Joanne Smith-Farrell
0
Number of Employees (Ranges)
51 – 200
Email Address
info@bebiopharma.com
Number of Employees
65
Investors
Bristol-Myers Squibb
Bristol-Myers Squibb
Alta Partners
Alta Partners
Atlas Venture
Atlas Venture
Longwood Fund
Longwood Fund
Takeda Ventures
Takeda Ventures
RA Capital Management
RA Capital Management
ARCH Venture Partners
ARCH Venture Partners
Founded Date
2020
Total Funding Amount (USD)
264,000,000
Latest Funding Round Date
October 22, 2024
Competitors
Aphios
Aphios
0
Arqule
Arqule
0
‌
Matterworks
0
CFO
‌
Angus Smith
Latest Funding Type
Series B
Series B
Country
United States
United States
0

Other attributes

Latest Funding Round Amount (USD)
82,000,000
No article content yet.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more companies like Be Biopharma

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.